Biliary Atresia Diagnosis and Management

Key Diagnostic Features

The American Academy of Pediatrics recommends that any conjugated bilirubin >25 μmol/L (>1.0 mg/dL when total bilirubin ≤5 mg/dL) requires urgent evaluation for biliary atresia or other cholestatic disease 2
Conjugated hyperbilirubinemia, characterized by a conjugated bilirubin level of 130 μmol/L, indicates cholestatic liver disease rather than physiologic jaundice in a 4-week-old infant 2
The presence of acholic stools is a hallmark clinical finding that distinguishes biliary atresia from other causes of neonatal cholestasis, according to the Mayo Clinic Proceedings 1
Dark urine occurs due to renal excretion of conjugated bilirubin, which is water-soluble, as noted in Pediatrics 2

Jaundice persisting beyond 2-3 weeks with conjugated hyperbilirubinemia defines pathologic neonatal cholestasis requiring immediate intervention, as stated in the Mayo Clinic Proceedings 1
Poor weight gain reflects malabsorption of fat-soluble vitamins and progressive liver dysfunction in infants with biliary atresia, according to the Mayo Clinic Proceedings 1
The Kasai portoenterostomy procedure must be performed ideally before 60 days of age to maximize success and prevent the need for liver transplantation, as recommended by the Mayo Clinic Proceedings 1
Urgent hepatobiliary ultrasound, hepatobiliary scintigraphy (HIDA scan), and liver biopsy are necessary for the diagnosis and management of biliary atresia, as suggested by the Mayo Clinic Proceedings 1